NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

As the norovirus cases continue to spread in the U.S., you can't rely on hand sanitizer alone to protect you, experts warn. Norovirus causes gastrointestinal symptoms like nausea, vomiting ...

A groundbreaking new gene therapy for sickle cell patients is now being rolled out for use on the NHS in England, as ITV News' Health Correspondent Rebecca Barry reports A £1.65 million treatment ...

A gene-editing therapy that offers a “functional cure” for some sickle cell patients has been approved for use on the NHS in England, in a move heralded as a positive “leap” forward. The National ...

"Sickle cell largely affects patients from African and African-Caribbean backgrounds, who are less likely to have a matching stem cell donor, and this community has been waiting years for a new ...

What would it look like to have a successful stem cell transplant? Would it be a cure for my sickle cell disease? It was a decision I could think about making because my sister was a genetic match ...

LONDON, Jan 31 (Reuters) - Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the National Institute for Health and Care ...

The NHS is rolling out a “revolutionary” gene therapy which effectively cures agonising sickle cell disease. Sickle cell is the fastest growing genetic condition in the UK where red blood ...

Asiawu Imam says the therapy will make a huge difference A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England.

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

A new innovative treatment for sickle cell disease will now be offered to patients in the NHS for the first time. A treatment, costing £1.65 provides hope for patients with severe sickle cell disease.

A sickle cell disease “cure” is to be offered to NHS patients for the first time. The £1.65 million gene therapy called exa-cel, also known under the brand name Casgevy, uses a Nobel Prize ...